Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 5
1981 8
1982 11
1983 12
1984 13
1985 18
1986 13
1987 18
1988 17
1989 29
1990 20
1991 31
1992 26
1993 22
1994 28
1995 31
1996 35
1997 43
1998 38
1999 52
2000 52
2001 68
2002 78
2003 91
2004 109
2005 122
2006 155
2007 164
2008 181
2009 218
2010 248
2011 284
2012 340
2013 385
2014 454
2015 516
2016 555
2017 552
2018 646
2019 729
2020 865
2021 981
2022 738
Text availability
Article attribute
Article type
Publication date

Search Results

8,068 results
Results by year
Filters applied: . Clear all
Page 1
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.
Li C, Zhan W, Yang Z, Tu C, Hu G, Zhang X, Song W, Du S, Zhu Y, Huang K, Kong Y, Zhang M, Mao Q, Gu X, Zhang Y, Xie Y, Deng Q, Song Y, Chen Z, Lu L, Jiang S, Wu Y, Sun L, Ying T. Li C, et al. Among authors: gu x. Cell. 2022 Apr 14;185(8):1389-1401.e18. doi: 10.1016/j.cell.2022.03.009. Epub 2022 Mar 10. Cell. 2022. PMID: 35344711 Free PMC article.
Emerging new therapeutic antibody derivatives for cancer treatment.
Jin S, Sun Y, Liang X, Gu X, Ning J, Xu Y, Chen S, Pan L. Jin S, et al. Among authors: gu x. Signal Transduct Target Ther. 2022 Feb 7;7(1):39. doi: 10.1038/s41392-021-00868-x. Signal Transduct Target Ther. 2022. PMID: 35132063 Free PMC article. Review.
Molecular landscapes of human hippocampal immature neurons across lifespan.
Zhou Y, Su Y, Li S, Kennedy BC, Zhang DY, Bond AM, Sun Y, Jacob F, Lu L, Hu P, Viaene AN, Helbig I, Kessler SK, Lucas T, Salinas RD, Gu X, Chen HI, Wu H, Kleinman JE, Hyde TM, Nauen DW, Weinberger DR, Ming GL, Song H. Zhou Y, et al. Among authors: gu x. Nature. 2022 Jul;607(7919):527-533. doi: 10.1038/s41586-022-04912-w. Epub 2022 Jul 6. Nature. 2022. PMID: 35794479
Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics.
Liu Q, Zhu F, Liu X, Lu Y, Yao K, Tian N, Tong L, Figge DA, Wang X, Han Y, Li Y, Zhu Y, Hu L, Ji Y, Xu N, Li D, Gu X, Liang R, Gan G, Wu L, Zhang P, Xu T, Hu H, Hu Z, Xu H, Ye D, Yang H, Li B, Tong X. Liu Q, et al. Among authors: gu x. Nat Metab. 2022 May;4(5):559-574. doi: 10.1038/s42255-022-00575-z. Epub 2022 May 23. Nat Metab. 2022. PMID: 35606596
Response to Takahashi.
Borregales LD, DeMeo G, Gu X, Cheng E, Dudley V, Schaeffer EM, Nagar H, Carlsson S, Vickers A, Hu JC. Borregales LD, et al. Among authors: gu x. J Natl Cancer Inst. 2022 Jul 26:djac146. doi: 10.1093/jnci/djac146. Online ahead of print. J Natl Cancer Inst. 2022. PMID: 35880831 No abstract available.
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study.
Liu J, Li J, Lin W, Shao D, Depypere L, Zhang Z, Li Z, Cui F, Du Z, Zeng Y, Jiang S, He P, Gu X, Chen H, Zhang H, Lin X, Huang H, Lv W, Cai W, Liang W, Liang H, Jiang W, Wang W, Xu K, Cai W, Wu K, Lerut T, Fu J, He J. Liu J, et al. Among authors: gu x. Int J Cancer. 2022 Jul 1;151(1):128-137. doi: 10.1002/ijc.33976. Epub 2022 Mar 21. Int J Cancer. 2022. PMID: 35188268 Clinical Trial.
8,068 results